Schwab Health Care
- SWHFX
- Price as of: Jan 13, 2021
-
$26.76
N/A N/A
- Primary Theme
- Health Care Sector Equity
- Fund Company
- Charles Schwab
- Share Class
SWHFX - Snapshot
Vitals
- YTD Return 2.7%
- 3 Yr Annualized Return 11.3%
- 5 Yr Annualized Return 9.7%
- Net Assets $806 M
- Holdings in Top 10 46.4%
52 WEEK LOW AND HIGH
Expenses
OPERATING RELATED FEES
- Expense Ratio 0.80%
SALES FEES
- Front Load N/A
- Deferred Load N/A
BROKERAGE FEES
- Turnover 73.00%
TRADING FEES
- Max Redemption Fee N/A
Min Investment
- Standard (Taxable) $0
- IRA N/A
Fund Classification
-
Primary Theme
Health Care Sector Equity
- Fund Type Open End Mutual Fund
- Investment Style Health
SWHFX - Profile
Distributions
- YTD Total Return 2.7%
- 3 Yr Annualized Total Return 11.3%
- 5 Yr Annualized Total Return 9.7%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 1.01%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameSchwab Health Care Fund™
-
Fund Family NameSchwab Funds
-
Inception DateJul 03, 2000
-
Shares Outstanding30933166
-
Share ClassNo Load
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerJonas Svallin
Fund Description
To pursue its goal, the fund primarily invests in equity securities issued by companies in the health care sector. The health care sector may include, for example, pharmaceutical and biotechnology companies, health care facilities operations, medical product manufacturers and suppliers, medical providers and medical services firms. It is the fund's policy that under normal circumstances it will invest at least 80% of its net assets in these securities; typically, the actual percentage will be higher. The fund will concentrate its investments in securities of companies in the health care sector.
SWHFX - Performance
Return Ranking - Trailing
| Period | SWHFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 2.7% | 0.3% | 17.2% | 75.00% |
| 1 Yr | 12.9% | 3.0% | 180.5% | 85.28% |
| 3 Yr | 11.3%* | 3.8% | 59.5% | 84.62% |
| 5 Yr | 9.7%* | 1.0% | 36.9% | 58.57% |
| 10 Yr | 14.6%* | 9.8% | 21.3% | 67.48% |
* Annualized
Return Ranking - Calendar
| Period | SWHFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2020 | 1.0% | -13.6% | 178.2% | 92.55% |
| 2019 | 12.5% | 3.8% | 63.8% | 91.72% |
| 2018 | -5.3% | -49.7% | 21.5% | 39.42% |
| 2017 | 11.9% | -59.8% | 54.4% | 73.33% |
| 2016 | -6.8% | -36.6% | 11.6% | 16.28% |
Total Return Ranking - Trailing
| Period | SWHFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 2.7% | 0.3% | 17.2% | 75.00% |
| 1 Yr | 12.9% | -2.3% | 180.5% | 80.98% |
| 3 Yr | 11.3%* | 2.4% | 59.5% | 83.22% |
| 5 Yr | 9.7%* | 1.0% | 36.9% | 57.14% |
| 10 Yr | 14.6%* | 9.8% | 21.3% | 67.48% |
* Annualized
Total Return Ranking - Calendar
| Period | SWHFX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2020 | 1.0% | -13.6% | 178.2% | 92.55% |
| 2019 | 12.5% | 3.8% | 63.8% | 91.72% |
| 2018 | -5.3% | -25.3% | 22.2% | 46.72% |
| 2017 | 11.9% | -10.8% | 54.4% | 80.74% |
| 2016 | -6.8% | -36.6% | 11.6% | 20.16% |
NAV & Total Return History
SWHFX - Holdings
Concentration Analysis
| SWHFX | Category Low | Category High | SWHFX % Rank | |
|---|---|---|---|---|
| Net Assets | 806 M | 6.3 M | 49 B | 52.91% |
| Number of Holdings | 98 | 24 | 459 | 45.35% |
| Net Assets in Top 10 | 363 M | 1.2 M | 19.6 B | 51.16% |
| Weighting of Top 10 | 46.41% | 8.8% | 76.9% | 18.60% |
Top 10 Holdings
- UnitedHealth Group Inc 6.03%
- Johnson & Johnson 5.42%
- Abbott Laboratories 5.30%
- Merck & Co Inc 5.03%
- AbbVie Inc 4.84%
- Amgen Inc 4.83%
- Thermo Fisher Scientific Inc 4.48%
- Eli Lilly and Co 4.22%
- AbbVie Inc 4.16%
- AbbVie Inc 4.16%
Asset Allocation
| Weighting | Return Low | Return High | SWHFX % Rank | |
|---|---|---|---|---|
| Stocks | 99.79% | 77.04% | 104.32% | 29.65% |
| Cash | 0.21% | -0.10% | 12.53% | 74.42% |
| Preferred Stocks | 0.00% | 0.00% | 5.23% | 19.19% |
| Other | 0.00% | -27.80% | 10.43% | 34.30% |
| Convertible Bonds | 0.00% | 0.00% | 0.06% | 7.56% |
| Bonds | 0.00% | 0.00% | 19.34% | 14.53% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | SWHFX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 61.64% | 100.00% | 4.07% |
| Utilities | 0.00% | 0.00% | 0.00% | 6.98% |
| Technology | 0.00% | 0.00% | 15.86% | 20.93% |
| Real Estate | 0.00% | 0.00% | 5.95% | 12.79% |
| Industrials | 0.00% | 0.00% | 5.94% | 16.28% |
| Financial Services | 0.00% | 0.00% | 4.10% | 42.44% |
| Energy | 0.00% | 0.00% | 0.03% | 7.56% |
| Communication Services | 0.00% | 0.00% | 4.69% | 10.47% |
| Consumer Defense | 0.00% | 0.00% | 33.59% | 12.79% |
| Consumer Cyclical | 0.00% | 0.00% | 1.19% | 15.70% |
| Basic Materials | 0.00% | 0.00% | 3.30% | 34.30% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | SWHFX % Rank | |
|---|---|---|---|---|
| US | 82.81% | 56.44% | 100.00% | 46.51% |
| Non US | 16.98% | 0.00% | 41.69% | 39.53% |
SWHFX - Expenses
Operational Fees
| SWHFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.80% | 0.08% | 25.14% | 64.07% |
| Management Fee | 0.53% | 0.00% | 1.25% | 22.67% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.40% | N/A |
Sales Fees
| SWHFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| SWHFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | 12.20% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| SWHFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 73.00% | 0.70% | 252.00% | 84.76% |
SWHFX - Distributions
Dividend Yield Analysis
| SWHFX | Category Low | Category High | SWHFX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 1.05% | 21.51% |
Dividend Distribution Analysis
| SWHFX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Monthly | Annually |
Net Income Ratio Analysis
| SWHFX | Category Low | Category High | SWHFX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 1.01% | -2.53% | 1.74% | 10.71% |
Capital Gain Distribution Analysis
| SWHFX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Dividend Payout History
| Date | Amount |
|---|---|
| Dec 14, 2018 | $0.235 |
| Dec 08, 2017 | $0.236 |
| Dec 12, 2016 | $0.205 |
| Dec 10, 2015 | $0.162 |
| Dec 09, 2014 | $0.214 |
| Dec 05, 2013 | $0.186 |
| Dec 06, 2012 | $0.334 |
| Dec 22, 2011 | $0.149 |
| Dec 23, 2010 | $0.187 |
| Dec 23, 2009 | $0.134 |
| Dec 23, 2008 | $0.089 |
| Dec 16, 2002 | $0.033 |
| Dec 17, 2001 | $0.005 |
SWHFX - Fund Manager Analysis
Managers
Jonas Svallin
Start Date
Tenure
Tenure Rank
Aug 03, 2012
8.42
8.4%
Jonas Svallin, CFA, Vice President and Head of Active Equities and leads the Active Equities portfolio management and research team. Prior to joining CSIM in 2012, Mr. Svallin spent nearly three years as a partner and a director of quantitative analytics and research at Fiduciary Research & Consulting, where he provided oversight of quantitative analytics and risk management efforts. From 2003 until 2009, Mr. Svallin was a principal and head portfolio manager at Algert Coldiron Investors LLC (now known as Algert Global). Prior to joining Algert, Mr. Svallin worked as a quantitative research associate at RCM Capital Management (now known as Allianz Global Investors) and a senior consultant at FactSet Research Systems.
Wei Li
Start Date
Tenure
Tenure Rank
Jun 14, 2013
7.55
7.6%
Wei Li, Ph.D., CFA, Senior Portfolio Manager at Charles Schwab Investment Management Inc. Prior to joining CSIM in 2012, Ms. Li spent more than ten years at Barclays Global Investors (now known as BlackRock, Inc.), where she held a number of positions. From 2001 to 2009, she worked in various roles in the Global Advanced Active group, including portfolio management and quantitative research for both U.S. and international equity markets. After 2009, she worked in the defined contribution research and product development area for almost two years.
Iain Clayton
Start Date
Tenure
Tenure Rank
Feb 27, 2015
5.85
5.9%
Iain Clayton, CFA, FRM, Senior Portfolio Manager, joined Charles Schwab Investment Management Inc in 2013, Mr. Clayton spent more than five years at SSI Investment Management, where he was a portfolio manager and director of quantitative research. In these roles, Mr. Clayton co-managed multiple investment strategies and developed quantitative models and valuation approaches. From 2004 to 2008, he worked as a portfolio manager and director at RCM Capital Management (now known as Allianz Global Investors) and helped manage various equity portfolios and developed fundamental-based stock selection models. Prior to that, he was a vice president at Eureka Investment Advisors for almost three years and also served as a senior quantitative analyst/assistant portfolio manager. He has also worked as a quantitative research analyst at RCM Capital Management.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.04 | 23.31 | 7.3 | 20.68 |